Publisher
Springer International Publishing
Reference10 articles.
1. Patsalos PN, Bourgeois BFD. The epilepsy prescriber’s guide to antiepileptic drugs. 2nd ed. Cambridge: Cambridge University Press; 2014.
2. Summary of Product Characteristics: Brivaracetam (Briviact). UCB Pharma Ltd. Last update 21 Jan 2016.
3. Ragueneau-Majlessi I, Levy RH, Bergen D, Garnet W, Rosenfeld W, Mather G, Shah J, Grundy JS. Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. Epilepsy Res. 2004;62:1–11.
4. Shinoda M, Akita M, Hasegawa M, Hasegawa T, Nabeshima T. The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs. Biol Pharm Bull. 1996;19:1090–2.
5. Sachdeo R. Lacosamide. In: Shorvon SD, Perucca E, Engel J, editors. The treatment of epilepsy. 3rd ed. Oxford: Blackwell Publishing; 2009. p. 527–34.